TMO vs. NVS, AZN, ABT, AMGN, ABBV, PFE, ISRG, ELV, SYK, and SNY
Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Novartis (NVS), AstraZeneca (AZN), Abbott Laboratories (ABT), Amgen (AMGN), AbbVie (ABBV), Pfizer (PFE), Intuitive Surgical (ISRG), Elevance Health (ELV), Stryker (SYK), and Sanofi (SNY). These companies are all part of the "medical" sector.
Novartis (NYSE:NVS) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.
Novartis pays an annual dividend of $2.43 per share and has a dividend yield of 2.4%. Thermo Fisher Scientific pays an annual dividend of $1.56 per share and has a dividend yield of 0.3%. Novartis pays out 32.8% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 10.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Novartis has raised its dividend for 4 consecutive years and Thermo Fisher Scientific has raised its dividend for 7 consecutive years.
Novartis has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.
Novartis has higher revenue and earnings than Thermo Fisher Scientific. Novartis is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
In the previous week, Thermo Fisher Scientific had 2 more articles in the media than Novartis. MarketBeat recorded 17 mentions for Thermo Fisher Scientific and 15 mentions for Novartis. Novartis' average media sentiment score of 1.12 beat Thermo Fisher Scientific's score of 0.91 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.
Thermo Fisher Scientific received 526 more outperform votes than Novartis when rated by MarketBeat users. Likewise, 81.12% of users gave Thermo Fisher Scientific an outperform vote while only 61.42% of users gave Novartis an outperform vote.
Novartis has a net margin of 31.33% compared to Novartis' net margin of 14.20%. Thermo Fisher Scientific's return on equity of 32.15% beat Novartis' return on equity.
13.1% of Novartis shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 0.0% of Novartis shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Novartis presently has a consensus price target of $115.00, indicating a potential upside of 15.08%. Thermo Fisher Scientific has a consensus price target of $605.31, indicating a potential upside of 6.16%. Given Thermo Fisher Scientific's higher probable upside, equities analysts plainly believe Novartis is more favorable than Thermo Fisher Scientific.
Summary
Thermo Fisher Scientific beats Novartis on 14 of the 21 factors compared between the two stocks.
Get Thermo Fisher Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Thermo Fisher Scientific Competitors List
Related Companies and Tools
